Brevilin A and Arnicolide D can activate the Caspase signalling pathway by regulating cell cycle proteins, inhibit the PI3K/AKT/mTOR and STAT3 signalling pathways, and thus inhibit the nasopharyngeal carcinoma cell growth [53,54]. The gene discussed is MTOR; the disease is nasopharyngeal carcinoma.